Tools
Tools
Kwambana, Brenda and Iroh Tam, Pui-Ying 
ORCID: https://orcid.org/0000-0002-3682-8892
(2023)
'Progress towards reduced-dose pneumococcal vaccine schedules for children in Africa.'. The Lancet Child & Adolescent Health, Vol 7, Issue 5, pp. 299-301.
|
Text
Kwambana-Adams_2023_Progress towards reduced-dose pneumococcal vaccine schedules for children in Africa.pdf - Accepted Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (380kB) | Preview |
Abstract
Pneumococcal conjugate vaccines (PCVs) have been available for more than 20 years 1 and incorporated into the childhood immunisation programmes of 168 countries. Although they have been remarkably successful at reducing the burden of pneumococcal disease globally, 1 there remain concerns about the sustainability of PCV programmes given the emerging threats and competing public health interests. Importantly, PCV remains the most expensive vaccine in childhood immunisation programmes, and between 2009 and 2020 Gavi, the Vaccine Alliance spent more than US$4 billion on PCV alone. In 2021, all but nine African nations had introduced PCV, with the high cost being a major barrier to introduction.
| Item Type: | Article |
|---|---|
| Subjects: | QW Microbiology and Immunology > Immunotherapy and Hypersensitivity > QW 806 Vaccination WC Communicable Diseases > Infection. Bacterial Infections > Bacterial Infections > WC 217 Pneumococcal infections |
| Faculty: Department: | Clinical Sciences & International Health > Clinical Sciences Department |
| Digital Object Identifer (DOI): | https://doi.org/10.1016/S2352-4642(23)00055-X |
| SWORD Depositor: | JISC Pubrouter |
| Depositing User: | JISC Pubrouter |
| Date Deposited: | 11 May 2023 14:19 |
| Last Modified: | 15 Oct 2024 06:56 |
| URI: | https://archive.lstmed.ac.uk/id/eprint/22231 |
Statistics
Actions (login required)
 |
Edit Item |